Role of Glycogen Synthase Kinase-3β Inhibitor AZD1080 in Ovarian Cancer
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s102506
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Informa UK Limited